Detalles de la búsqueda
1.
Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trial.
BMC Med
; 22(1): 107, 2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38454451
2.
A durable 4-1BB-based CD19 CAR-T cell for treatment of relapsed or refractory non-Hodgkin lymphoma.
Chin J Cancer Res
; 34(1): 53-62, 2022 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35355931
3.
Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies.
BMC Cancer
; 21(1): 198, 2021 Feb 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33632155
4.
The clinical outcomes of fresh versus cryopreserved CD19-directed chimeric antigen receptor T cells in non-Hodgkin lymphoma patients.
Cryobiology
; 96: 106-113, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32721392
5.
Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.
Blood
; 129(12): 1658-1668, 2017 03 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-28100459
6.
ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma.
Cancer Cell Int
; 19: 32, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30814910
7.
Prognostic value of 18F-fluorodeoxyglucose positron emission tomography using Deauville criteria in diffuse large B cell lymphoma treated with autologous hematopoietic stem cell transplantation.
Chin J Cancer Res
; 31(1): 162-170, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30996574
8.
PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity.
BMC Cancer
; 18(1): 910, 2018 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30241515
9.
Outcome and Prospective Factor Analysis of High-dose Therapy Combined with Autologous Peripheral Blood Stem Cell Transplantation in Patients with Peripheral T-cell Lymphomas.
Int J Med Sci
; 15(9): 867-874, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30008598
10.
NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53.
Mod Pathol
; 30(6): 854-876, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28281555
11.
Prognostic value of pre- and post-transplantation 18F-fluorodeoxyglucose positron emission tomography results in non-Hodgkin lymphoma patients receiving autologous stem cell transplantation.
Chin J Cancer Res
; 29(6): 561-571, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29353979
12.
PEG-asparaginase in BFM-90 regimen improves outcomes in adults with newly diagnosed lymphoblastic lymphoma.
Chin J Cancer Res
; 29(1): 66-74, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28373755
13.
Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome.
Ann Hematol
; 95(12): 2023-2031, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27595760
14.
Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
Mod Pathol
; 28(12): 1555-73, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26541272
15.
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program.
Blood
; 121(20): 4021-31; quiz 4250, 2013 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-23449635
16.
Safety and efficacy of bevacizumab combined with R-CHOP regimen in seven Chinese patients with untreated diffuse large B-cell lymphoma.
Cancer Cell Int
; 14(1): 5, 2014 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-24438119
17.
[Clinical value of flow cytometry in assessing bone marrow involvement of non-Hodgkin's lymphoma].
Zhonghua Yi Xue Za Zhi
; 94(38): 2996-3000, 2014 Oct 21.
Artículo
en Zh
| MEDLINE | ID: mdl-25547702
18.
Primary gastrointestinal mantle lymphoma with massive bleeding: a case report and literature review.
Chin J Cancer Res
; 25(2): 250-3, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23592907
19.
Prognostic value of interim (18)F-FDG PET/CT in diffuse large B-cell lymphoma.
Chin J Cancer Res
; 25(1): 95-101, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23372347
20.
Efficacy and safety of relmacabtagene autoleucel, an anti-CD19 chimeric antigen receptor T cell, in relapsed/refractory B-cell non-Hodgkin's lymphoma: 2-year results of a phase 1 trial.
Bone Marrow Transplant
; 58(3): 288-294, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36477110